NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $424 | -79.9% | 16,689 | -71.4% | 0.00% | -82.4% |
| Q1 2023 | $2,109 | +6.0% | 58,340 | +16.2% | 0.02% | -41.4% |
| Q4 2022 | $1,989 | -99.9% | 50,217 | -6.9% | 0.03% | -12.1% |
| Q3 2022 | $2,515,000 | +3.4% | 53,963 | -2.8% | 0.03% | +10.0% |
| Q2 2022 | $2,432,000 | +170.2% | 55,494 | +399.7% | 0.03% | +233.3% |
| Q4 2021 | $900,000 | +270.4% | 11,106 | +432.4% | 0.01% | +200.0% |
| Q3 2021 | $243,000 | -83.2% | 2,086 | -79.8% | 0.00% | -85.7% |
| Q1 2021 | $1,443,000 | – | 10,343 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |